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Abstract 
 
Cell growth, proliferation, differentiation, and survival are influenced by the availability of 
oxygen. The effect of hypoxia on embryonic cells and the underlying molecular mechanisms 
to maintain cellular viability are still poorly understood. In this study, we show that hypoxia 
during Xenopus embryogenesis rapidly leads to a significant developmental delay and to cell 
apoptosis after prolonged exposure. We provide strong evidence that hypoxia does not affect 
somitogenesis but affects the number of mitotic cells and muscle-specific protein 
accumulation in somites, without interfering with the expression of MyoD and MRF4 
transcription factors. We also demonstrate that hypoxia reversibly decreases Akt 
phosphorylation and increases the total amount of the translational repressor 4E-BP, in 
combination with an increase of the 4E-BP associated with eIF4E. Interestingly, the inhibition 
of PI3-Kinase or mTOR, with LY29002 or rapamycin respectively, triggers the 4E-BP 
accumulation in Xenopus embryos. Finally, the overexpression of the non-phosphorylatable 
4E-BP protein induces, similar to hypoxia, a decrease in mitotic cells and a decrease in 
muscle-specific protein accumulation in somites. Taken together, our studies suggest that 4E-
BP plays a central role under hypoxia in promoting the cap-independent translation at the 
expense of cap-dependent translation and triggers specific defects in muscle development. 
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Introduction 
 
Oxygen (O2) is an environmental and developmental signal regulator involved in 
several events such as energy homeostasis, development and progenitor cell differentiation. 
Hypoxia can arise from physiological events (e.g. exercise, travel at high altitude) as well as 
from pathophysiological conditions (e.g. tissue ischemia, inflammation, solid tumors) 
(Papandreou et al., 2005; Wouters et al., 2005). Understanding cellular responses to hypoxia 
is of great importance since hypoxia impacts normal development and the malignant 
progression of a solid tumor (Rivard, 1986; Wouters et al., 2005; Sharma et al., 2006; Simon 
and Keith, 2008; Wouters and Koritzinsky, 2008; Dunwoodie, 2009; Rodricks et al., 2010).  
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The cellular response to hypoxia depends on the severity of the hypoxic insult and 
may result in complex gene expression changes to maintain cellular viability through 
transcriptional and post-transcriptional events. This response is largely driven by a 
transcriptional program initiated by stabilization of hypoxia-inducible factors (HIF) 
(Guillemin and Krasnow, 1997; Semenza, 2003; Cummins and Taylor, 2005; Wouters et al., 
2005). HIF-1 and HIF-2 promote transcription of more than 60 putative downstream genes 
that affect hypoxia tolerance, energy homeostasis, angiogenesis and tumor growth (Semenza, 
2003).  
 
Besides HIF stabilization, the PI3K/Akt signalling pathway is an important contributor 
to hypoxia tolerance (Mazure et al., 1997; Barry et al., 2007). Akt is a serine/threonine kinase 
that resides downstream of PI3K and phosphorylates a variety of substrates (Kandel and Hay, 
1999; Brazil and Hemmings, 2001). Akt phosphorylates and inhibits the tuberous sclerosis 
complex (TSC2), a negative regulator of the mammalian target of rapamycin (mTOR). 
Consequently mTOR is activated and stimulates the cap-dependent translation (Hay and 
Sonenberg, 2004). 
 
Cap-dependent translation requires the assembly of an active eIF4F (eukaryotic 
initiation factor 4F) complex at the m7GpppN cap structure present at the 5’ terminus of the 
mRNA (Hay and Sonenberg, 2004; Kapp and Lorsch, 2004; Holcik and Sonenberg, 2005; 
Sonenberg and Hinnebusch, 2009). The eIF4F complex consists of the cap-binding protein, 
eIF4E, a scaffolding protein, eIF4G and an ATP-dependent helicase, eIF4A. Formation of 
eIF4F facilitates the recruitment of the pre-initiation complex, 43S, which is necessary to 
initiate translation. The assembly of the cap-binding complex eIF4F is a key step of the 
translational regulation and is regulated through a set of eIF4E-binding proteins (4E-BPs) 
controlled by mTOR-mediated phosphorylation (Hay and Sonenberg, 2004; Sonenberg and 
Hinnebusch, 2009). 4E-BPs reversibly bind to eIF4E in their hypophosphorylated form 
obstructing the interaction between eIF4E and eIF4G and consequently preventing the 
formation of eIF4F complex (Pause et al., 1994; Haghighat et al., 1995). Interestingly, several 
cellular mRNAs use an alternative mechanism of translation initiation, involving an internal 
ribosomal entry site (IRES) at the 5’ untranslated region and are translated efficiently when 
cap-dependent translation is impaired under a variety of stress conditions including serum 
deprivation, irradiation, apoptosis and hypoxia (Holcik et al., 2000).  
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Hypoxia results in a rapid inhibition of protein synthesis through the repression of the 
initiation step of mRNA translation (Wouters et al., 2005). This can be regulated by a hypoxia 
dependent inhibition of eIF4F as evidence by a reduction of eIF4E/eIF4G association and a 
corresponding increase of eIF4E/4E-BP (Koritzinsky et al., 2006). In the same way, hypoxia 
rapidly and reversibly triggers hypophosphorylation of mTOR and its effector 4E-BP in 
human embryonic kidney cells (Arsham et al., 2003). In addition, hypoxia rapidly induces a 
reversible increase in 4E-BP protein levels in sea urchin embryos (Le Bouffant et al., 2006) 
and FoxO activates 4E-BP mRNA transcription in Drosophila embryos undergoing oxidative 
stress or after nutrient starvation (Tettweiler et al., 2005). While the 4E-BP translational 
inhibitory functions and mechanisms involved in its regulation have been extensively studied 
in vitro, the biological role of 4E-BP in developing organisms is unclear to date. Few studies 
have been performed regarding the effects of hypoxia on embryonic development, even 
though O2 has been involved in the development of several pathologies of human pregnancy 
(Unger et al., 1988; Julian, 2011). Xenopus laevis embryos contain a 4E-BP protein (Fraser et 
al., 1999) but little is known about its role during embryonic development, particularly during 
hypoxic stress.  
 
Our objective was to determine the effects of hypoxia on vertebrate embryonic 
development and muscle formation and to examine the involvement of 4E-BP in mediating 
these hypoxic effects. Here, we show that hypoxia causes oxygen-dependent growth 
retardation, apoptosis and lethality after prolonged exposure. Exposure to hypoxic conditions 
also decreases Akt phosphorylation and induces a reversible increase in 4E-BP downstream 
protein amount that associates with eIF4E in hypoxia. Moreover, analysis of muscle 
development provides strong evidence that hypoxia does not affect somitogenesis but affects 
the accumulation of muscle-specific proteins in somites, independently of mRNA variation. 
Finally, our data show for the first time that overexpression of the non-phosphorylatable 4E-
BP protein causes effects similar to hypoxia on somite cells. Taken together, our studies 
suggest that 4E-BP plays a key role in mediating the hypoxia-induced defects in muscle 
formation, without affecting the expression of myogenic transcription factors. 
 
Results 
 
Hypoxia causes growth retardation, lethality and apoptosis 
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To investigate the effects of hypoxia on early development, we exposed Xenopus 
embryos to several levels of oxygen from the end of the gastrulation (stage 13) to late tailbud 
stages (stage 42). Control embryos were exposed to 21% O2 corresponding to normoxia and 
hypoxic embryos were exposed to 10% or 5% O2 that represent moderate and strong hypoxic 
stress, respectively. These conditions were validated by measurements of dissolved oxygen 
level and by quantitative real-time PCR (qRT-PCR) to determine HIF-1α transcription level 
which is tightly controlled by cellular oxygen tension (Gorlach, 2009) and its known VEGF 
target gene. The oxygen partial pressure in the medium was proportional to the oxygen level 
in the hypoxic chamber and HIF-1α and VEGF mRNA expression increased significantly in 
relation to oxygen availability (Fig. S1). Moreover, we performed Western blot analyses with 
an antibody against the phospho-p38-MAPK, a member of the class of mitogen-activated 
protein kinases that are responsive to stress stimuli. As shown in Figure 1A-B, phospho-p38-
MAPK was undetectable at stage 21 and was detected at very low level at stage 25 in control 
embryos. When embryos were subjected to 10% O2, levels of phospho-p38-MAPK were not 
significantly higher as compared to the control at any stage (Fig. 1A-B). However, levels 
were dramatically higher in embryos exposed to 5% O2 at stages 21 and 25 when compared to 
the control embryos and to embryos subjected to 10% O2 (Fig. 1A-B). These results show that 
exposure to 5% O2 causes a strong cellular stress response during embryonic development 
whereas 10% O2 seems to have less of an effect. 
External embryo morphology was observed and compared to Nieuwkoop and Faber 
table stage illustrations (Nieuwkoop and Faber, 1994). As shown in Figure 1C-D, both 
moderate and strong hypoxia slowed down embryonic development rate. Forty-two hours of 
hypoxia treatment caused a significant retardation in Xenopus development without affecting 
external embryo morphology (Fig. 1D). When normoxic embryos have reached stage 30, 
embryos exposed to 10% O2 have reached stage 28 and embryos exposed to 5% O2 have 
reached stage 25. Moreover, hypoxic embryos maintain their delayed growth through 
development (Fig. 1C).  
 Depigmentation of embryos and dissociation of tissues were used as indicators to 
assess hypoxia related lethality. The number of dead embryos was counted (Fig. 1E). 
Xenopus embryos exposed for 24h to 10% O2 had a survival rate of 77% while those exposed 
for 24h to 5% O2 had a stark decrease in survival represented by a 48% survival rate. Since 
hypoxia causes significant embryonic death depending on oxygen availability, the apoptosis 
patterns in relation to the oxygen concentration was analysed. Embryos (n=15) were fixed at 
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stage 25 when the cellular stress marker phospho-p38-MAPK level was higher and sections 
were treated with TUNEL. TUNEL positive cells were counted on frontal sections of control 
and hypoxic embryos, and the average of positive cells per embryo is presented in Figure 1F. 
Apoptosis was 77% higher in embryos exposed to strong hypoxia (5% O2) compared to the 
control. In embryos exposed to 10% O2 the number of apoptotic cells was 43% higher 
compared to the control embryos suggesting that hypoxia causes apoptosis depending on the 
oxygen level. 
Strikingly, embryos exposed to hypoxia and especially to 5% O2 did not make any 
movement when pricked with fine pliers compared to control embryos, which ran off (data 
not shown). This observation suggests that hypoxia caused strong motility defects probably 
by affecting muscles. To further investigate the effect of hypoxia on muscle development, 
experiments were performed on embryos from stage 21 to stage 25, after the formation of the 
first somites (Nieuwkoop and Faber, 1994) and before death of the majority of embryos 
exposed to strong hypoxia. 
 
Hypoxia decreases Akt phosphorylation in Xenopus embryos 
The serine/threonine protein kinase Akt plays a critical role in metabolism, cell 
survival, mRNA translation, proliferation and cell cycle regulation. In addition, Akt signalling 
pathway has been shown to regulate myoblast proliferation and differentiation (Bodine et al., 
2001; Wilson and Rotwein, 2007; Wu et al., 2010). Based on these data, the Akt signalling 
activation was analysed by Western blot using two anti-phospho-Akt antibodies (Fig. 2). 
Akt was phosphorylated on Thr308 and Ser473 in control embryos suggesting an 
activation of Akt protein during the normal development. Interestingly, in embryos exposed to 
hypoxia, the level of phospho-Akt decreased in an oxygen concentration-dependent manner at 
stages 21 and 25. The phosphorylation status of Akt protein was significantly weaker under 
strong hypoxia (5% O2) in both stages compared to control and to 10% O2-exposed embryos, 
although each batch present variability and in some cases hypoxic embryos already presented 
phospho-Akt at stage 25 (Fig. 2). Therefore, the Akt signalling protein is inhibited in hypoxia 
during early embryonic development particularly in 5% O2 context. Otherwise, the Akt 
phosphorylation level was more affected at stage 21 than stage 25. 
 
Hypoxia increases the amount of 4E-BP protein, which binds to eIF4E 
The translational repressor 4E-BP is known to be a downstream substrate of the Akt 
signalling pathway (Gingras et al., 1998). Akt mediated phosphorylation of the translational 
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repressor 4E-BP can subsequently lead to inactivation or degradation of 4E-BP (Elia et al., 
2008). We then performed Western blot analyses to determine 4E-BP protein levels in 
embryos exposed to hypoxia. As shown in Figure 3A-B, 4E-BP protein levels were 
significantly higher in hypoxia-exposed embryos at stages 21 and 25, compared to the 
controls maintained under normoxic conditions. Moreover, 4E-BP protein levels were 
significantly higher in embryos subjected to 5% O2 than to 10% O2, suggesting that hypoxia-
induced overexpression of 4E-BP depends on oxygen availability. To know if the increase of 
4E-BP protein was due to transcriptional regulation, we performed qRT-PCR. As shown in 
Figure 3D, the relative 4E-BP mRNA level did not change significantly under hypoxia. 
In mammals, 4E-BP has been shown to bind to eIF4E in its hypophosphorylated form. 
Therefore, decrease of Akt activity induced by hypoxia should consequently increase the 
amount of 4E-BP associated with eIF4E. To validate this hypothesis, we used m7GTP affinity 
beads to test if overexpressed 4E-BP is able to bind its target, eIF4E. Protein extracts were 
incubated with m7GTP-conjugated Sepharose beads and bound proteins were analysed by 
Western blot with antibodies against 4E-BP and eIF4E. After m7GTP purification, Western 
blot analysis revealed that the amount of 4E-BP associated with eIF4E increased significantly 
in embryos exposed to 5% and 10% O2 (Fig. 3C). Taken together, these data demonstrate that 
hypoxia reduces Akt phosphorylation level and leads to 4E-BP accumulation, which is able to 
bind to eIF4E.  
It was then important to show links between 4E-BP amount regulation and Akt 
signalling pathway activity in Xenopus embryos. Indeed, if an active Akt signalling pathway 
maintains a low level of 4E-BP, it is then conceivable that embryos treatment with 
LY294002, a well-established inhibitor of PI3-kinase acting upstream of Akt, will modify the 
amount of 4E-BP protein in normoxic condition. To test this hypothesis, 4E-BP protein 
amount was analysed by Western-blot in control and treated embryos. As expected, 2 hours 
treatment with 50 µM of LY294002 affected Akt phosphorylation state and triggered an 
increase of 4E-BP protein amount (Fig. 3E). In addition, since mTOR acts downstream Akt, 
we then tested the effect of rapamycin, a mTOR activity inhibitor. Interestingly, this drug 
induced a dose-dependent accumulation of 4E-BP in 3 hours treated embryos (Fig. 3F). 
Taken together, these data suggest that the 4E-BP protein level is dependent of the 
PI3K/Akt/mTOR signalling pathway in Xenopus embryos.  
 
Effects of hypoxia exposure are reversible upon reoxygenation 
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We investigated whether hypoxic effects are reversible by exposing embryos to 5% O2 
until stage 21 and then subjecting a subset of embryos to normoxia (i.e. reoxygenation; Fig. 
4A). Protein levels of 4E-BP as well as the phosphorylation of p38-MAPK and Akt were 
analysed by Western blot. As shown in Figure 4B, phospho-p38-MAPK level decreased in 
reoxygenated embryos showing that the cellular stress was abolished. Moreover, embryonic 
death was prevented in the subset of embryos subsequently exposed to normoxia (9%) 
compared to the subset of embryos kept under hypoxic condition (54%). Interestingly, both 
phospho-Akt and 4E-BP protein levels returned to basal levels observed in controls 
(normoxia) suggesting that this signalling pathway was reactivated. 
We have shown that the reoxygenation of the embryos triggers a decrease of the 4E-
BP protein level and that 4E-BP amount is under a rapamycin-sensitive pathway. We then 
hypothesized that the decrease of 4E-BP amount triggered by reoxygenation of the embryos 
should be altered after rapamycin treatment. To test this idea, embryos were exposed to 5% 
O2 until stage 21 and shifted to normoxia in absence or presence of rapamycin. After 15, 30 
and 45 min of reoxygenation, the level of 4E-BP was analysed by Western blot. As shown in 
Figure 4C, 4E-BP amount was more important in reoxygenated embryos cultured for 30 and 
45 min in presence of rapamycin compared to those cultured in absence of the drug. However, 
4E-BP amount decreased in both cases suggesting that this time of exposure to rapamycin 
(less than 1 hour) seems to be not sufficient to induce the maximal effect of this drug and to 
maintain a high level of 4E-BP. In agreement with this, we show that 3 hours treatment with 
rapamycin was required to induce an increase of the 4E-BP amount in normoxia (Fig. S2). 
Altogether, these results show that effects of hypoxia are reversible when oxygen is 
available, suggesting a correlation between oxygen concentration and embryonic survival as 
well as a correlation between oxygen concentration, the PI3K/Akt/mTOR signalling pathway 
and the stability of 4E-BP. 
 
Hypoxia specifically decreases the number of mitotic cell in somites 
Our data show that hypoxia decreased Akt activation and increased the levels of 
translational repressor 4E-BP. Since Akt have been shown to be involved in cell proliferation 
and that control of polypeptide synthesis plays an important role in this mechanism, we used 
phosphorylated-Histone H3 (phospho-H3) as a mitosis marker. Immunodetection was 
performed with the anti-phospho-H3 antibodies on cryostat sections of stage 25 embryos 
(n=8). The number of phospho-H3 positive cells was determined and the average of positive 
cells per tissues is presented in Figure 5. The number of mitotic cells in the neural tube, the 
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notochord and the epidermis was not significantly affected in strong hypoxia. However, the 
number of positive cells was strongly reduced (90%) in somites of embryos exposed to 5% O2 
as compared to control. 
These results suggest that hypoxia specifically induces a decrease in the number of 
mitotic cell in somites, suggesting a decrease in somite cell proliferation. 
 
Hypoxia does not affect somitogenesis but affects the accumulation of specific proteins in 
muscle cells  
In vertebrate embryos, somites are regular transient structures repeated along the 
anterior/posterior axis of the embryo, which then differentiate into a part of the dermis, bone, 
cartilage and skeletal muscles. During somitogenesis, somitic cells are stacked in blocks and 
undergo a 90° rotation relative to the anteroposterior axis of the embryo to form myotome 
fibers that are aligned parallel to the notochord (Keller, 2000). Movements of nuclei were 
followed during progressive alignment and, at the end of rotation, nuclei are arranged in 
regularly ordered stripes so that one stripe corresponds to one somite. 
In this study, we previously observed that embryos exposed to hypoxia did not make 
any movement compared to control embryos, suggesting muscle defects. In addition, we 
showed that hypoxia specifically decreases mitotic cell in somites and negatively regulates the 
serine/threonine protein kinase Akt that has been involved in muscle cell differentiation 
(Bodine et al., 2001; Wilson and Rotwein, 2007; Wu et al., 2010). To further investigate the 
effects of hypoxia on somitogenesis and muscle formation, we sectioned embryos and 
analysed the morphology of somites by immunostaining with the F59 antibodies against MHC 
(myosin heavy chain) protein and myotome/skeletal muscle-specific monoclonal 12/101 
antibodies (Kintner and Brockes, 1984). On frontal sections, blocks of somitic cells were 
discernable, any changes in somite number was observed and segmentation of the presomitic 
mesoderm did not appear to be affected in hypoxia (Fig. 6A-D). Interestingly, we noticed that 
both the F59 (Fig. 6A-B) and the 12/101 antibodies (Fig. 6C-D) stainings were dramatically 
weaker in the embryos exposed to hypoxia as compared to the control. These data were 
confirmed by Western blot showing that the 12/101 protein level was weaker in embryos 
exposed to 10% and 5% O2 as compared to the control (Fig. 6E). 
To investigate whether hypoxic effects are reversible, embryos were exposed to 5% O2 
until stage 21 and then a subset of them was subjected to normoxia. As shown in Figure S3, 
the 12/101 staining was higher in reoxygenated embryos compared to hypoxic embryos, 
indicating that some hours of reoxygenation partially reversed the phenotype in muscles. 
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Since the expression of MHC protein and the 12/101 muscle marker were decreased in 
hypoxic embryos, it is possible that hypoxia affects the somite fate by inhibiting the 
expression of genes coding for transcription factors involved in muscle cell differentiation. 
Therefore we investigated whether hypoxia interfered with the myogenic signalling pathway 
by analysing the expression patterns of XMyoD and XMRF4, early and late markers of 
muscle cell differentiation respectively. The expression of these specific proteins was 
analysed by immunostaining of frontal sections. Comparison between hypoxic and control 
embryos did not reveal any significant differences in the expression of both proteins. Indeed, 
anti-XMyoD and anti-XMRF4 antibodies revealed identical nuclear stainings in both 
normoxic (21% O2) and hypoxic (5% O2) embryos at stage 25 (Fig. 6 F-Q). 
Interestingly, the decrease of MHC protein amount induced by hypoxia was 
independent of Myh 1, 4, 8 and 6 mRNAs variation (encoding for the MHC protein 
recognized by the F59 antibody) as shown by qRT-PCR analysis (Fig. 6R and S4). Moreover 
and as expected, qRT-PCR analysis also showed no significant variations of MyoD mRNA 
level for stage 25 under hypoxic conditions (Fig. 6S).  
In the epidermis of hypoxic embryos, the expression of p63 transcription factor, one of 
the earliest markers of epidermis differentiation, as well as the acetylated tubulin protein, a 
late marker of ciliated cells differentiation, were not affected (Fig. 6T-W).  
Together, these results show that hypoxia does not affect somitogenesis and the 
expression of at least two transcription factors involved in muscle cell differentiation. 
However, hypoxia affects the accumulation of muscle-specific proteins in somites without 
affecting stability or transcription of mRNAs. 
 
Overexpression of a non-phosphorylatable 4E-BP protein affects the accumulation of 
muscle-specific proteins in somites  
The results above show that hypoxia increases functional 4E-BP protein levels, as 
indicated by eIF4E protein binding. In addition, hypoxia affects the accumulation of muscle-
specific proteins. We then hypothesized that maintained eIF4E sequestration by 4E-BP is 
involved in the muscle cell protein accumulation. To validate this possibility, both 
blastomeres of two-cell stage embryos were injected with mRNA encoding for full-length 4E-
BP protein (WT-4E-BP) and Western blot analysis was used to establish 4E-BP protein levels 
at stage 25. Unexpectedly, in this condition, only a very small amount of WT-4E-BP was 
detectable (Fig. 7A), suggesting that the overexpressed protein was rapidly degraded. Since it 
has been recently suggested that phosphorylation of 4E-BP may promote its degradation (Elia 
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et al., 2008), we hypothesized that the injection of mRNA encoding for a non-
phosphorylatable 4E-BP protein should maintain high overexpression of 4E-BP protein and 
efficiently sequester eIF4E. Most of the data available to date indicates that mTOR is the 
main kinase of 4E-BP (Brunn et al., 1997; Burnett et al., 1998). Therefore, both blastomeres 
of two-cell stage embryos were then injected with mRNA encoding for a 4E-BP mutated 
protein (4A-4E-BP), in which all the four mTOR regulated residues in 4E-BP were mutated to 
alanine (Martineau et al., 2012). Abolishing the possibility of phosphorylation on these four 
serine/threonine-to-alanine substitution has been shown to render 4E-BP constitutively active 
in sequestrating eIF4E (Oulhen et al., 2009). As expected, 4A-4E-BP mRNA injection 
induced a significant increase in 4E-BP protein levels without exposure to hypoxia (Fig. 7A). 
Interestingly, overexpression of 4E-BP did not significantly affect developmental stage, 
apoptosis and embryo survival (data not shown).  
We then checked that the 4A-4E-BP mutated protein associated efficiently with the 
endogenous eIF4E using m7GTP affinity beads. Protein extracts were incubated with m7GTP-
conjugated Sepharose beads and bound proteins were analysed by Western blot with 
antibodies against 4E-BP and eIF4E. As shown in Figure 7B, WT-4E-BP and 4A-4E-BP 
proteins bind eIF4E, indicating that the mutation of the phosphorylation sites of 4E-BP did 
not alter its functionality other than stabilizing the protein. 
To investigate the effects of overexpressing 4E-BP protein in somites, embryos were 
unilaterally injected at the four-cell stage into the presumptive somite region with mRNA 
encoding for 4A-4E-BP or WT-4E-BP as a control. Immunostaining of sectioned embryos 
revealed that the 4A-4E-BP protein was unilaterally detected in somites (Fig. 7C). Both the 
4A-4E-BP and WT-4E-BP mRNA injected embryos developed normally according to the 
external morphology (Fig. 7D-E). However, Figure 7F shows a significant decrease in the 
number of mitotic cells in somites of 4A-4E-BP mRNA injected side compared to the control 
side of embryos, suggesting that overexpression of non-phosphorylatable 4E-BP protein 
induces a decrease in somite cell proliferation. Immunohistochemical analyses with 12/101 
antibodies and Hoechst were performed. Interestingly, the 12/101 staining was dramatically 
weaker in the 4A-4E-BP mRNA injected side compared to the control side as well as to the 
WT-4E-BP mRNA injected embryos (Fig. 7G-H) while qRT-PRC analyses show that the 
injection of 4A-4E-BP mRNA did not alter the Myh 1, 4, 8 and 6 mRNAs expression level 
(Fig. 7I and S4). Then, immunohistochemistry and qRT-PCR analysis of MyoD expression 
showed that this transcription factor is correctly expressed in 4A-4E-BP mRNA injected 
embryos at both protein and mRNA levels (Fig. 7 J-L and M, respectively). 
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These results show that overexpression of the non-phosphorylatable 4E-BP protein 
leads to similar muscle effects compared to those observed in embryos exposed to hypoxia on 
the number of mitotic cells, the expression of muscle transcription factor and on the 
accumulation of muscle-specific proteins in the somite cells, independently of mRNAs 
variation. 
 
Discussion 
  
Our data show that exposure to hypoxia for 24 hours significantly reduced growth and 
delayed embryonic development in an oxygen-dependant manner. These effects are similar to 
those observed in mouse, chicken and sea urchin embryos (Le Bouffant et al., 2006; Sharma 
et al., 2006; Ream et al., 2008). Hypoxia also affected embryonic survival depending on the 
oxygen availability. During human pregnancy, acute hypoxia observed during retroplacental 
haemorrhage, intoxication with CO, and acute decompensation of maternal diabetes mellitus, 
has been linked with the sudden death of the fetus. Our model is much more linked with 
chronic hypoxia of the fetus. In such cases, chronic hypoxia leads to intrauterine growth 
retardation (IUGR; Vandenbosche and Kirchner, 1998) defined by a fetal weight 
corresponding that less than 10% of predicted fetal weight for gestational age. Its annual 
incidence is estimated between 4% to 7% of the total gestation number and the major 
conditions that can give rise to IUGR are maternal hypertension, maternal diabetes mellitus, 
maternal systemic lupus, smoking, certain infectious diseases, and lastly fetal chromosomal 
abnormalities like 21 trisomy or Turner syndrome. Interestingly, since Xenopus embryos 
develop externally, we show that growth retardation and embryonic death were independent 
on the maternal behaviour and placenta formation. Moreover, the growth retardation of 
embryos may reflect defects in timing of development suggesting alterations of 
developmental timer. However, this feature of hypoxia was not explored. 
 
In the same way, we demonstrate that both strong and moderate hypoxia induce 
apoptosis. While the p38-MAPK has been shown to be involved in apoptosis (Bulavin et al., 
1999; She et al., 2000; Zarubin and Han, 2005), in our hands there is no clear correlation 
between apoptotic patterns and phospho-p38-MAPK levels. Therefore, hypoxia may activate 
other mechanisms involved in apoptosis induction, such as the activation of pro-apoptotic 
factors. Since Akt was shown to be involved in cell survival (Dudek et al., 1997), the 
regulation of this kinase could be a good candidate to activate apoptosis in hypoxia. Indeed, 
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Bcl-2-Associated Death promoter (BAD) protein, caspase 9, and FoxO have been identified 
as targets of Akt. Activated Akt can phosphorylate and inactivate these factors, whereas the 
inhibition of Akt induces apoptosis (Datta et al., 1997; Kandel and Hay, 1999; Brazil and 
Hemmings, 2001). In agreement with this hypothesis, we show that Akt is reversibly 
dephosphorylated in hypoxia suggesting a link between this signalling pathway and the 
hypoxia-induced apoptosis in Xenopus embryos. However, we cannot exclude the 
involvement of other signalling pathways in the induction of apoptosis. Interestingly, the pro-
apoptotic factor Bmf (Bcl-2-Modifying Factor), a member of the Bcl-2 family, has been 
shown to act as a sensor for stress that associates with the repression of the cap-dependent 
translation (Grespi et al., 2010). 
 
Cap-dependent translation is correlated with the availability of the eukaryotic initiation 
factor eIF4E, which constitutes a major checkpoint for mRNA translation regulation (Richter 
and Sonenberg, 2005). The availability of eIF4E has been implicated in hypoxic responses in 
part by the phosphorylation of 4E-BP, a downstream target of the Akt signalling pathway 
(Wouters et al., 2005). Strikingly, we demonstrate that in Xenopus embryos hypoxia induced 
overexpression of a functional 4E-BP protein able to sequester eIF4E. The fact that 4E-BP 
association with eIF4E increases in hypoxia is in agreement with the Akt inhibition, since the 
4E-BP/eIF4E dissociation complex is dependent of an active Akt signalling pathway and the 
phosphorylation state of 4E-BP. While the phosphorylation control of 4E-BP has been 
extensively studied (Armengol et al., 2007), little is known about the significant role of the 
variation in 4E-BP levels as a means of control of the availability of eIF4E (Cormier et al., 
2003). The first demonstration that modification of 4E-BP levels may influence cell fate has 
been obtained in sea urchin where 4E-BP is fully degraded shortly after fertilization to allow 
embryonic development (Salaun et al., 2003). Moreover, hypoxia was shown to result in a 
reversible increase in 4E-BP protein levels in sea urchin embryos (Le Bouffant et al., 2006). 
In agreement with this, we show that the amount of the 4E-BP protein increases dramatically 
in Xenopus embryos following hypoxia therefore supporting the hypothesis that, besides its 
phosphorylation state, 4E-BP overexpression is also important to inhibit eIF4E availability 
and subsequent cap-dependent translation. 
 
However, little is known about the mechanisms that control 4E-BP expression since 
the amount of protein in the cell reflects both protein synthesis and degradation. Therefore, a 
working model is proposed in Figure 8 to illustrate mechanisms that could be involved in 4E-
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BP overexpression during embryonic development in hypoxia. On the one hand, deactivated 
Akt in hypoxia could prevent the phosphorylation of FoxO members resulting in nuclear 
translocation of these transcription factors and expression of FoxO-regulated genes such as 
4E-BP, as shown in Drosophila embryos under dietary restriction and oxidative stress 
(Tettweiler et al., 2005). It is important to note that in pancreatic cells, 4E-BP mRNA 
transcription is regulated by the transcription factor Smad4 after TGFβ treatment (Azar et al., 
2009) and consequently, it cannot be excluded that 4E-BP mRNA transcription is under the 
control of different transcription factors. However, qRT-PCR analyses did not show any 
significant variation in 4E-BP mRNA levels in embryos exposed to 10% and 5% O2, 
suggesting that the 4E-BP gene transcription was not responsible for the increase in 4E-BP 
protein amount at stages 21 and 25. On the other hand, deactivated Akt in hypoxia prevents 
the activation of its downstream mTOR protein and therefore prevents the phosphorylation of 
4E-BP. Since it was shown that inhibition of proteasomal activity enhances the level of 
hypophosphorylated 4E-BP in Jurkat cells, 4E-BP protein can be activated and stabilized to 
accumulate in hypoxic cells via the inhibition of its degradation pathway. In agreement with 
this hypothesis, we show that inhibition of the PI3K/Akt pathway or mTOR activity, using 
LY294002 or rapamycin respectively, leads to an increase in 4E-BP amount in normoxic 
embryos, suggesting that the 4E-BP level is dependent of the Akt signalling pathway and 
under a rapamycin-sensitive pathway. Interestingly, since the inhibition of mTOR, known to 
phosphorylate 4E-BP, leads to its accumulation in normoxic embryos and slows its 
degradation in reoxygenated embryos, our data also suggests that the phosphorylation state of 
4E-BP is associated with its stability, probably due to the inhibition of its degradation 
pathway. However, an additional increase in 4E-BP mRNA translation could also participate 
in the accumulation of 4E-BP in hypoxic cells (Fig. 8).  
 
Importantly, the inhibition of the initiation step of mRNA translation by 4E-BP has 
been proposed to act as a cellular survival mechanism involving decreased protein synthesis 
in order to conserve oxygen because protein synthesis is extremely energy costly. Teleman et 
al. (Teleman et al., 2005) and Tettweiler et al. (Tettweiler et al., 2005) provide support for the 
role of 4E-BP in mediating Drosophila embryonic survival under unfavourable conditions. In 
agreement with this idea, we demonstrate that effects of hypoxia exposure are reversible when 
oxygen is available and embryonic death was reduced with reoxygenation concomitant with 
the decrease in 4E-BP level. Moreover, inhibition of 4E-BP mRNA translation with specific 
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Morpholino injection in two-cell stage embryos strongly induced lethality in normoxia, 
suggesting that a basal level of 4E-BP is required to regulate protein synthesis and ensure 
survival of embryos during the early embryonic development (data not shown). 
 
In this study, we also observed that embryos exposed to hypoxia did not make any 
movement. In vertebrate embryos, somites are regular transient structures repeated along the 
anterior/posterior axis of the embryo, which then differentiate into a part of the dermis, bone, 
cartilage, tendon-cell lineages and skeletal muscles. Since the sclerotome is formed at stage 
37 and the dermatome is a single layer of cells under the epidermis, somites of embryos at 
stages 21 and 25 are mainly composed of myotome cells which will give rise to skeletal 
muscle. Because premyoblast proliferation is known to be an early step of the myogenesis, 
one hypothesis was that hypoxia exposure affects cell proliferation in developing somites. In 
agreement with this, we found that hypoxia induces a 90% decrease in mitotic cell in somites. 
Interestingly, 4E-BP is known to be implicated in the inhibition of cell proliferation 
(Armengol et al., 2007; Azar et al., 2009) and, in the same way, we show that overexpression 
of a non-phosphorylatable 4E-BP protein in somites induced a decrease in cell proliferation. 
Consequently, hypoxia-induced 4E-BP overexpression is in agreement with the inhibition of 
myoblast proliferation. However, how is this only cell type affected by hypoxia remains an 
open question. One hypothesis is that the hypoxia-induced 4E-BP overexpression occurs 
selectively in myoblast precursors. Therefore, it would be interesting to perform in situ 
analysis of protein distribution in the embryos exposed to hypoxia. 
In addition, we observed that the 12/101 monoclonal antibodies that recognize a not 
yet identified epitope of the differentiated muscle cells (Kintner and Brockes, 1984) produced 
a weaker signal in hypoxic embryos. We demonstrate that hypoxia does not affect 
mechanisms involved in the segmentation of the presomitic mesoderm but affects 
accumulation of muscle-specific proteins during the embryonic development. However, 
hypoxia does not disturb the protein expression pattern of both XMyoD and XMRF4, early 
and late markers of muscle cell fate respectively, suggesting that oxygen does not interfere 
with the events leading to the expression of the myogenic transcription factors in somite 
nuclei. Therefore, hypoxia could affect cap-dependent translation of mRNA produced 
downstream MyoD and MRF4 activation. The fact that MyoD and MRF4 were not affected 
following hypoxia treatment or 4E-BP overexpression lead us to propose that the translation 
of these two transcription factors mRNAs is under cap-independent control which is mostly 
mediated by mRNA structural element called IRES (Hellen and Sarnow, 2001). Interestingly, 
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IRES have been identified in several mammalian mRNAs, mainly in control genes such as 
transcription factors and growth factors (Vagner et al., 2001). For instance, functional IRESs 
have been recently identified in Fibroblast Growth Factor 1 (Martineau et al., 2004; Conte et 
al., 2009), which plays a crucial role in myoblast differentiation. It is noteworthy that a 
number of genes including the hypoxia-inducible genes encoding HIF-1α remain 
preferentially translated when eIF4E is sequestered by its repressor 4E-BP (Wouters and 
Koritzinsky, 2008) and we show that HIF-1α mRNA levels increased depending on the 
oxygen availability. Therefore, 4E-BP overexpression could represent an oxygen-sensitive 
pathway that occurs upstream changes in gene expression mediated by HIF-1 in hypoxia. This 
regulation of the translational machinery by hypoxia in Xenopus embryos might support 
mRNA-selective translation. In agreement with this hypothesis and with our data, it has been 
recently published that translation facilitates genes classes like transcription and signal 
transduction during acute hypoxia, whereas it represses the expression of genes involved in 
cell growth and protein metabolism (van den Beucken et al., 2011). Therefore, determination 
of the number and the nature of mRNAs translated in hypoxia condition is now an important 
goal. 
 
Finally, an important step in muscle development is the abundant synthesis of specific 
proteins required for muscle cell contraction including actin and myosin that approximately 
occupy 80% of the cytoplasmic volume. To determine whether the translation machinery and 
particularly the availability of the cap binding protein eIF4E was involved in muscle defects, 
two constructs were used. The first one codes for full-length sea urchin 4E-BP protein (WT-
4E-BP). The second one codes for 4E-BP mutated protein (4A-4E-BP) in which four 
phosphorylation sites of 4E-BP were mutated dramatically affecting the release of 4E-BP 
from eIF4E (Oulhen et al., 2009). Our data support that the phosphorylation state of the 4E-
BP protein is crucial to ensure the stability of the protein in Xenopus embryo since the 4E-BP 
protein accumulate in 4A-4E-BP injected embryos but not in WT-4E-BP. Moreover, since 
mTOR is the major kinase of these phosphorylatable sites, this is in good agreement that the 
regulation of 4E-BP amount is under the PI3K/Akt/mTOR axis. We also observed that the 
12/101 monoclonal antibodies produced a weaker signal although MyoD was expressed in 
4A-4E-BP injected embryos. We therefore demonstrate that overexpression of the non-
phosphorylatable 4E-BP protein leads to similar effect on muscle proteins than in embryos 
exposed to hypoxia (i.e. decrease in 12/101 signal but not in MyoD expression). The data 
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suggest for the first time that the hypoxia-induced 4E-BP could be responsible for defects in 
muscle formation during the early vertebrate development of the myotomes, without affecting 
specification by the myogenic transcription factors but preventing the abundant synthesis of 
muscle-specific proteins.  
 
Materials and methods 
 
Xenopus laevis embryos, hypoxia exposure and measurement of dissolved oxygen 
Xenopus laevis embryos were obtained as previously described (Hidalgo et al., 2009). After 
the gastrulation events (stage 13 according to Nieuwkoop and Faber (Nieuwkoop and Faber, 
1994)), embryos were cultivated in 0.1X MMR with several oxygen levels (10% and 5% O2) 
in hypoxic chambers. The oxygen partial pressure in the medium was measured at several 
oxygen levels with an apparatus used to measure blood gases (Radiometer ABL520, 
Copenhagen, Denmark). 
 
Plasmid constructs and mRNA injection experiments 
The 342-bp fragment corresponding to sea urchin wild type 4E-BP or to mutant 4A-4E-BP 
was isolated from the pGex4T1 plasmid (Oulhen et al., 2009) and inserted into the pCS2+ 
vector digested by Bamh1 and Xho1. Synthetic capped mRNAs were made by in vitro 
transcription as described in Djiane et al. (Djiane et al., 2000). All blastomeres or two 
blastomeres of two-cell stage or four-cell stage embryos were injected depending on the 
experiment. 
 
Isolation of eIF4E and associated proteins 
Xenopus embryos were collected and homogenized in lysis buffer (50 mM Tris HCl, 100 mM 
NaCl, pH 7,5, 2 mM EDTA, 2 mM EGTA, 50 mM β-glycerophosphate, 50 mM sodium 
fluoride, 1 mM Na3VO4, 120 nM okadaic acid, 1 mM PMSF, 1% Triton X100) supplemented 
with protease inhibitors. Lysates were centrifuged for 15 minutes at 14,000 g at 4°C. Isolation 
of eIF4E and its partners from embryo extracts was performed using m7GTP beads 
(Amersham Biosciences). Briefly, 2 mg proteins were incubated with 25 µg of m7GTP 
sepharose beads for 1 hour at 4°C. The beads were washed with 2 ml of 1X binding buffer 
containing 100 mM NaCl. Laemmli sample buffer was added directly to the beads and 
denatured at 95°C for 5 minutes before Western blot analysis. 
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Western blot analysis 
Xenopus embryos were collected and homogenized in lysis buffer (50 mM Tris HCl, 100 mM 
NaCl, pH 7,5, 2 mM EDTA, 2 mM EGTA, 50 mM β-glycerophosphate, 50 mM sodium 
fluoride, 1 mM Na3VO4, 120 nM okadaic acid, 1 mM PMSF, 1% Triton X100) supplemented 
with protease inhibitors. Protein samples, separated by 12% SDS-PAGE, were transferred to 
nitrocellulose membranes (Hybond) as described by Towbin (Towbin et al., 1979). The 
membranes were blocked in 5% non-fat dry milk and incubated with the following primary 
antibodies: anti-α-Tubulin (T0926, Sigma), anti-4E-BP1 (9452, Cell Signaling), anti-eIF4E 
(9742, Cell Signaling), anti-p38-MAPK (9212, Cell Signaling), anti-phospho-p38-MAPK 
(9211, Cell Signaling), anti-phospho-Akt Ser473 (9271, Cell Signaling), anti-phospho-Akt 
Thr308 (9275, Cell Signaling), anti-Akt total (9272, Cell Signaling), anti-sea urchin 4E-BP 
(alpha-69, (Oulhen et al., 2010)), 12101 (DSHB). After washing they were incubated with the 
appropriate secondary antibodies: anti-rabbit HRP conjugated (111-036-045, Jackson 
ImmunoResearch), anti-mouse HRP conjugated (115-036-062, Jackson ImmunoResearch) 
and detected by chemiluminescence. All experiments were repeated at least 3 times. For 
quantification, blots were exposed to X-ray film for various time points and the films were 
scanned and analysed using the ImageJ software from the NIH. 
 
Immunochemistry 
Embryos were embedded with 15% cold-water fish gelatin (FLUKA, biochemika) and 15% 
sucrose. Tissues were sectioned at 14 µm thickness by a cryostat (Leica CM 3050S). Sections 
were blocked in 20% goat serum and the following primary antibodies were used: mouse 
monoclonal 12/101 (DSHB, 1:2000), F59 (DSHB, 1:100), alpha-69 ((Oulhen et al., 2010), 
1:100), mouse anti-MyoD (D7F2, DSHB), guinea pig anti-MRF4 (kindly provided by Dr B. 
Della Gaspera, Université Paris 5, France, 1:50), mouse anti-P63 (Abcam, 1:50), mouse anti-
acetylated tubulin (Sigma 6-11B-1, 1:500). After washing they were incubated with the 
appropriate secondary antibodies: anti-mouse CY3 conjugated (Sigma C2181, 1:100), anti-
rabbit FITC conjugated (Jackson ImmunoResearch 111-095-144, 1:40), anti-guinea pig Alexa 
488 conjugated (Invitrogen A11073, 1:500). Nuclei were stained with Hoechst H33258 
(Sigma, 1:1000). Sections were washed and then mounted in Immunomount (Thermo electron 
corporation).  
All imaging was done at room temperature. Immunofluorescent staining was imaged using a 
Nikon Eclipse E800 microscope equipped with a QEi Evolution camera (Media Cybernetics) 
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(ARC N° 7867). A 4x (Plan 0.1 NA), 10x (Plan-apochromat 0.45 NA) or 20x (Plan-
apochromat 0.75 NA) were used and the image acquisition software was Image-Pro Plus. 
 
Quantitative PCR 
Total RNAs were isolated from 6 embryos (stages 21 and 25) using the RNeasy mini kit 
(Quiagen) according to the manufacturer instructions. All primers were designed using Primer 
Express Software. PCR reactions were carried out using SYBR green (Applied Biosystems) 
on a StepOnePlus (Applied Biosystems). All experiments were repeated at least 3 times on 
separate experiment and the real-time PCR was also performed in duplicate. The results were 
analysed using the 2-∆∆Ct method (Livak and Schmittgen, 2001). The relative expression of 
genes is shown normalized to the expression of the house-keeping gene RPL13 although 
several house-keeping genes were tested to validate the results. The real-time PCR primers 
are given Table S1. 
 
TUNEL staining and proliferation assays 
Embryos (n=15) were fixed and sectioned. TUNEL (terminal deoxynucleotidyl transferase–
mediated deoxyuridinetriphosphate nick end-labelling) staining was carried out following the 
protocol as previously described (Hidalgo et al., 2009). Sections were mounted in 
Immunomount (Thermo electron corporation) and positive cells were counted, on all sections 
of embryos in several tissues, by microscopy at a magnification of 100X, in non-overlapping 
fields. 
Proliferation assays were performed on sections of embryos (n=8) stained with the rabbit anti-
human phospho-Histone H3 antibody (Ser 10, mitosis marker, Euromedex H5110-14B, 
1:500) and the anti-rabbit alkaline phosphatase-conjugated antibody (Jackson 
Immunoresearch 111-055-144, 1:5000). Positive cells were counted, on all sections of 
embryos in several tissues, in both the control and the hypoxic embryos by microscopy at a 
magnification of 100X, in non-overlapping fields. 
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Figure legends 
 
Fig. 1. Hypoxia causes growth retardation, lethality and apoptosis. 
(A) Western blot analysis. Protein extracts at stages 21 and 25 from embryos exposed to 21%, 
10% and 5% O2 were studied by Western blot using anti-phopsho-p38-MAPK and anti-p38-
MAPK. Anti-tubulin alpha antibodies were used as a loading control. A 5% O2 exposure 
caused a strong cellular stress during the embryonic development. (B) Densitometric 
quantification of phospho-p38-MAPK from immunoblots in the different experimental 
conditions as described in material and method. (C) Growth of embryos at 21°C in functions 
of time and of oxygen rate. Less oxygen is available more the retardation is important and 
hypoxic embryos maintained their delay. (D) Lateral view of embryos 42 hours after 
fertilization. When control embryos were stage 30, embryos exposed to 10% O2 were stage 28 
and embryos exposed to 5% O2 were stage 25. (E) Embryo survival in function of oxygen 
level. Moderate hypoxia permits survival but strong hypoxia causes significant embryonic 
death. (F) Stage 25 embryos were sectioned (n=15) and TUNEL stained. Positive cells were 
counted on frontal sections of control and hypoxic embryos. The average of positive cells per 
embryos is compared on the graph. Apoptosis was promoted with hypoxia. *P<0.05; 
**P<0.005; ***P<0.001. Scale bar = 400 µm. 
 
Fig. 2. Hypoxia decreases Akt phosphorylation.  
(A) Western blot analysis. Protein extracts at stages 21 and 25 from embryos exposed to 21%, 
10% and 5% O2 were resolved by electrophoresis, blotted and reacted with anti-Thr308-Akt, 
anti-Ser473-Akt or anti-Akt antibodies. Anti-tubulin alpha antibodies were used as a loading 
control. (B-C) Densitometric quantification of Thr308-Akt (B) and Ser473-Akt (C) from 
immunoblots in the different experimental conditions as described in material and method. 
The level of phospho-Akt decreased in hypoxia. *P<0.05; **P<0.005. 
 
Fig. 3. Hypoxia increases the amount of 4E-BP protein which binds to eIF4E. 
(A) Western blot analysis. Protein extracts from embryos exposed to 21%, 10% and 5% O2, at 
stages 21 and 25 were resolved by electrophoresis, blotted and reacted with anti-4E-BP 
antibodies (9452, Cell Signaling). Anti-α tubulin antibodies were used as a loading control. 
(B) Densitometric quantification of 4E-BP from immunoblots in the different experimental 
conditions as described in material and method. *P<0.05; **P<0.005; ***P<0.001. (C) 
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Isolation of eIF4E and its partners from stage 25 embryo extracts was performed using 
m7GTP Sepharose beads before Western blot analysis. Immunoblots with anti-4E-BP and 
anti-eIF4E antibodies were performed. An anti-tubulin alpha antibody was used as a 
purification control in m7GTP samples. 4E-BP binds eIF4E. (D) qRT-PCR of 4E-BP mRNA 
in normoxia (21% O2) and hypoxia (10 and 5% O2) at stages 21 and 25. No significant 
variation of the mRNA amount was detected. (E) Western blot analysis. Protein extracts from 
embryos exposed to several concentration of LY294002, a well-established inhibitor of PI3-
kinase which acts upstream of Akt, were resolved by electrophoresis, blotted and reacted with 
anti-4E-BP and anti-Thr308-Akt antibodies. Anti-α tubulin antibodies were used as a loading 
control. Treatment with 50 µM LY294002 affected Akt phosphorylation state and triggered 
an increase of 4E-BP protein amount. (F) Western blot analysis. Protein extracts from 
embryos exposed to rapamycin, a compound known to block mTOR activity, were resolved 
by electrophoresis, blotted and reacted with anti-4E-BP and anti-Thr308-Akt antibodies. Anti-
α tubulin antibodies were used as a loading control. Treatment with rapamycin induced a 
dose-dependent increase of the 4E-BP amount. 
 
Fig.  4. Effects of hypoxia exposure are reversible upon reoxygenation.  
(A) Experimental design. Embryos were exposed to 5% O2 until stage 21 and then some of 
them were replaced under normal condition (reoxygenation) whereas the others still 
developed in hypoxia. Control embryos were exposed to 21% O2 (normoxia). (B) Western 
blot analysis using anti-4E-BP, anti-phospho-p38-MAPK, anti-Thr308-Akt and anti-Ser473-
Akt antibodies were performed. Anti-tubulin alpha antibodies were used as a loading control. 
When oxygen is available, the P-p38-MAPK, P-Akt as well as the 4E-BP protein levels return 
to the basal level observed in control. The embryonic death at stage 25 was reduced (9%) 
when replaced under normal conditions compared to hypoxia (54%). (C) Embryos were 
exposed to 5% O2 until stage 21 and shifted to normoxia in absence (-) or presence (+) of 
rapamycin. The level of 4E-BP was analysed by Western blot after 15, 30, 45 min of 
reoxygenation. Anti-tubulin alpha antibodies were used as a loading control. 4E-BP amount 
was more important in reoxygenated embryos cultured in presence of rapamycin compared to 
those cultured in absence of the drug. 
 
Fig. 5. Hypoxia specifically decreases the number of mitotic cell in somites. 
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Stage 25 embryos were sectioned (n=8) and immunodetections were performed with the anti-
phospho-Histone H3 antibody. Positive cells were counted on frontal sections of control and 
hypoxic embryos. The average of positive cells per tissues is compared on the graph. The 
number of positive cells was specifically reduced in somites of embryos exposed to 5% O2. 
*P<0.05. 
 
Fig. 6. Hypoxia does not affect somitogenesis but affects the accumulation of specific 
proteins in muscle cells. 
(A-D) Stage 25, control (A-C) and 5% O2-exposed embryos (B-D). Sections were nuclei 
stained with Hoechst (blue) and immunostained with the F59 antibodies (red; A-B) or with 
the 12/101 antibodies (red; C-D). Both stainings disappeared in hypoxic embryos. (E) 
Western blot analysis using the 12/101 antibodies and anti-alpha tubulin antibodies as a 
loading control. The 12/101 protein level was weaker in embryos exposed to hypoxia. (F-Q) 
Stage 25 control embryo and 5% O2-exposed embryos sectioned and stained with Hoechst 
(blue) and immunostained with the anti-MyoD (G, J) and anti-MRF4 (M,P) antibodies (red). 
No significant differences in the localisation and expression of MyoD and MRF4 were 
detected. (R-S) qRT-PCR of Myh 1, 4 and 8 mRNAs (R) and MyoD mRNA (S) in normoxia 
(21% O2) and hypoxia (10 and 5% O2) at stage 25. The amount of mRNAs remained constant 
regardless of oxygen availability. (T-W) 21% and 5% O2-exposed embryos, sectioned and 
stained with Hoechst (blue) and immunostained with the anti-P63 (red; T,U) and anti-
acetylated tubulin antibodies (red; V, W). P63 was still expressed in nuclei of cells and 
acetylated tubulin in ciliated cells of the epidermis. Scale bar = 100 µm. 
 
Fig. 7. Overexpression of a non-phosphorylatable 4E-BP protein affects the 
accumulation of muscle-specific proteins in somites. 
(A-B) Embryos were injected at the two-cell stage on both blastomeres with mRNA coding 
for a full-length sea urchin 4E-BP protein (WT-4E-BP) and coding for a 4E-BP mutated 
protein (4A-4E-BP). (A) Protein extracts from stage 25 embryos were studied using an anti-
4EBP antibody (alpha 69). Immunoblot with anti-tubulin alpha antibodies was used as a 
loading control. The 4A-4E-BP injection induced an overexpression of the 4E-BP protein 
without hypoxia exposure while in the WT-4E-BP injected embryos the 4E-BP protein level 
was much lower. (B) Isolation of eIF4E and its partners from stage 25 embryo extracts was 
performed using m7GTP Sepharose beads before Western blot analysis. Immunoblots with 
anti-4E-BP (alpha 69) and anti-eIF4E antibodies were performed. WT-4E-BP and 4A-4E-BP 
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proteins bind eIF4E. (C) Embryos were unilaterally injected at the four-cell stage into the 
presumptive somite region with the WT-4E-BP or 4A-4E-BP constructs. At stage 25, embryos 
were fixed, sectioned and stained with an anti-4EBP antibody (alpha 69; red) and Hoechst 
(blue). 4E-BP protein was unilaterally detected in somites of 4A-4E-BP injected embryos. (D-
E) External views of embryos. Lateral views of both control (D) and 4A-4E-BP injected (E) 
embryos. They developed normally. (G-H) At stage 25, control and injected embryos were 
fixed, sectioned and stained with the 12/101 antibodies (red) and Hoechst (blue). (G) Frontal 
section of WT-4E-BP injected embryo. (H) Frontal section of 4A-4E-BP injected embryo. The 
12/101 staining was weaker in the 4A-4E-BP injected side (lower part) compared to the 
control side and compared to the WT-4E-BP injected embryos. (I) qRT-PCR of Myh 1, 4, 8 
mRNAs in normoxia (21% O2) at stage 25 of non injected (CT), WT-4E-BP (WT) and 4A-4E-
BP (4A) injected embryos. The amount of mRNAs remained constant. (J-L) 4A-4E-BP 
injected embryos at stage 25, sectioned and stained with the anti-MyoD antibody (red, K) and 
Hoechst (blue, L); merged image (J). (M) qRT-PCR of MyoD mRNA in normoxia (21% O2) 
at stage 25 of non injected (CT), WT-4E-BP (WT) and 4A-4E-BP (4A) injected embryos. The 
amount of mRNAs remained constant. Scale bar = 200 µm. 
 
Fig. 8. Working model.  
In normoxia (left part), phospho-Akt indirectly activates mTOR that stimulates protein 
translation notably through phosphorylation and inhibition of 4E-BP. It is possible that 
phospho-4E-BP is degraded via the proteasome pathway. Akt can also phosphorylate FoxO 
members resulting in cytoplasmic retention and inactivation of this transcription factor. 
Myoblasts can proliferate and differentiate in this context. In hypoxia (right part), 4E-BP 
overexpression can be explained by two different ways. One possibility is that deactivated 
Akt prevents the inhibition of FoxO members therefore resulting in the expression of FoxO-
regulated genes such as 4E-BP. Another possibility is that deactivated Akt prevents the 
mTOR activation and therefore the phosphorylation and degradation of 4E-BP. Consequently, 
4E-BP protein can accumulate in the cytoplasm of hypoxic cells to repress the initiation step 
of the mRNA translation. In this context, transcription factors are correctly expressed in 
nuclei to specify myoblast lineage but hypoxia-induced 4E-BP causes muscle defects 
preventing the synthesis of specific muscle proteins. 
 
S1.  
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(A) The oxygen partial pressure in the medium was measured at several oxygen levels. The 
dissolved oxygen level (mmHg) was proportional to the oxygen level in the hypoxic chamber 
(%). (B-C) qRT-PCR analysis of HIF-1α (B) and VEGF (C) mRNA from embryos exposed to 
21%, 10% and 5% O2. A significant increase of HIF-1α and VEGF mRNA expression in 
relation to oxygen availability was observed. *P<0.05. 
 
S2.  
Western blot analysis. Protein extracts from embryos exposed for several hours to 80 µM 
rapamycin were resolved by electrophoresis, blotted and reacted with anti-4E-BP and anti-
Thr308-Akt antibodies. Anti-α tubulin antibodies were used as a loading control. 3 hours 
treatment with rapamycin triggered an increase of the 4E-BP amount without affecting Akt 
phosphorylation. 
 
S3.  
(A-C) Stage 25, control (A), reoxygenated (B) and 5% O2-exposed embryos (C). Sections 
were nuclei stained with Hoechst (blue) and immunostained with the 12/101 antibodies (red). 
(D) Western blot analysis using the 12/101 antibodies and anti-alpha tubulin antibodies as a 
loading control. The 12/101 staining was higher in reoxygenated embryos compared to 
hypoxic embryos but did not return to basal levels observed in controls (normoxia). Scale bar 
= 100 µm. 
 
S4.  
(A-B) qRT-PCR of Myh 6 mRNAs from embryos at stage 25 (A) exposed to 21%, 10% and 
5% O2, and from embryos (B) non injected (CT), WT-4E-BP (WT) and 4A-4E-BP (4A) 
injected embryos. The amount of mRNAs remained constant. 
 
 
Table S1. qRT-PCR primer sequences. 








  Forward Reverse 
Myh 1/4/8 5'-TGCCACAGAAAACAAGGTCAAA-3' 5'-TCGAGAGCTGCCATTTCTTCA-3' 
Myh 6 5'-ACCTTTCTGCATGAGCCAGC-3' 5'-TCACACAGAAGAGACCTGAATATGTG-3' 
HIF1alpha 5'-CCAGGCTATTGGAATTGGTACC-3' 5'-GGCCCAGGATCAACATTTGT-3' 
4E-BP 5'-GGCACCCTCTTCTCCACCA-3' 5'-CGACGGTCCAAAAGAAACTTG-3' 
MyoD 5'-CTCCGATGGCATGATGGATT-3' 5'-CTTCTCCTGGAGCCGCAG-3' 
ODC 5'-GGGCAAAGGAGCTTAATGTGG-3' 5'-TGCCAACATGGAAACTCACAC-3' 
Actin b 5'-TCTATTGTGGGTCGCCCAAG-3' 5'-TTGTCCCATTCCAACCATGAC-3' 
EEF1alpha 5'-CTTCTCAGGCCGACTGTGC-3' 5'-ATTCACCAACACCAGCAGCA-3' 
RPL13 5'-GGAATCCCACCTCCCTATGAC-3' 5'-GCGCACAATCTTCAGAGCAG-3' 
VEGF 5'-CTATGCCTGGAGAGGGAGACC-3' 5'-CATGCTGCGCTCGTACACTT-3' 
 



